Search Results for: cancer stem cells

Was Einstein Wrong About Insanity?

Einstein

Was Einstein wrong on his definition of insanity? “Insanity”, said Einstein, “is doing the same thing over and over again and expecting different results.” But in science, how sane is it to expect experiments to give precisely the same results? How big a problem is irreproducibility in science? Experiments on that question have given variable …

Was Einstein Wrong About Insanity? Read More »

Where’s the Beef? Reality Check on Test Tube Burger Baloney

Mark-Post-of-Maastricht-University-UnVeiling-Test-Tube-Burger

What is the deal with the crazy hullaballoo over the so-called stem cell test tube burger? On the surface, this pseudo-burger sounds kinda cool in a geeky, comic book kind of way, but when I dug just a little deeper, it turns out I’m left asking: where’s the beef? After the burger was mentioned briefly on …

Where’s the Beef? Reality Check on Test Tube Burger Baloney Read More »

What are VSELs and why they can’t be used for treatment?

Bigfoot_Sightings_in_USA-295x3001

One of the more controversial areas in the stem cell field has been over a Sasquatch like stem cell type that only a handful of researchers have been able to find and study: very small embryonic-like stem cells (VSELs). Why VSELs get no respect A Sasquatch is a generally thought to be mythological creature from …

What are VSELs and why they can’t be used for treatment? Read More »

FDA & Japanese Health Ministry (厚生労働省) To Develop Joint iPS cell clinical rules by 2015 while first human studies to begin earlier in 2014

In a rare sign of stem cell international regulatory unity, the Japanese Health Ministry (厚生労働省) and the US FDA have agreed to develop a joint, unified regulatory framework for clinical studies of human iPS cells for use in treating retinal diseases. Presumably the rules would also guide clinical use of iPS cells to treat other …

FDA & Japanese Health Ministry (厚生労働省) To Develop Joint iPS cell clinical rules by 2015 while first human studies to begin earlier in 2014 Read More »

BioTime CEO Mike West Interview Part 2: Geron & hESC

Michael-West-PhD-CEO-of-BioTime-1-934x10241

When you want to both know the real history of the pluripotent stem cell-based biotech industry and perspectives on its future, there are only a handful of people to turn to and one of them is definitely Dr. Michael West, CEO of BioTime. I’m doing a several part series of blog posts on a lengthy …

BioTime CEO Mike West Interview Part 2: Geron & hESC Read More »

Myriad SCOTUS Decision: Can you have a gene patent?

stem-cell-patent-300x2751

Should a company be able to have a gene patent and more generally and practically speaking can genes be patented? Patent and IP issues always raise a myriad of questions so what about a patent case on a company called Myriad? Complicated, right? If genes in their natural form cannot be patented, does that mean …

Myriad SCOTUS Decision: Can you have a gene patent? Read More »

Interview with Regenerative Surgeon, Dr. Allan Wu

Over the last few weeks, I have enjoyed talking with and interviewing Dr. Allan Wu, of The Morrow Institute on stem cell cosmetic procedures. I was impressed greatly by his talk at the World Stem Cell Summit last year. Dr. Wu is a fellowship trained Surgical Molecular Biologist with a background in Molecular Embryology and a board …

Interview with Regenerative Surgeon, Dr. Allan Wu Read More »

Opinion: iPS cell pre-clinical data should be published before starting first human clinical trials

It is always exciting when a biomedical technology as revolutionary as iPS cells is on the cusp of being used in patients for the first time. In the last few days stories have reported about how a proposed clinical trial based on iPS cells has completed several regulatory steps and is closer to starting. This …

Opinion: iPS cell pre-clinical data should be published before starting first human clinical trials Read More »